+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
From
C-X-C Chemokine Receptor Type 2 Market Report 2025 - Product Thumbnail Image

C-X-C Chemokine Receptor Type 2 Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Immunocytokines Market Report 2025 - Product Thumbnail Image

Immunocytokines Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Celiac Disease Treatment Market Report 2025 - Product Thumbnail Image

Celiac Disease Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Tenosynovitis Drugs Market Report 2025 - Product Thumbnail Image

Tenosynovitis Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Hashimotos Disease Global Market Report 2025 - Product Thumbnail Image

Hashimotos Disease Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Periodic Fever Syndrome - Global Strategic Business Report - Product Thumbnail Image

Periodic Fever Syndrome - Global Strategic Business Report

  • Report
  • February 2026
  • 390 Pages
  • Global
From
Nasal Corticosteroids Market - Global Strategic Business Report - Product Thumbnail Image

Nasal Corticosteroids Market - Global Strategic Business Report

  • Report
  • February 2026
  • 469 Pages
  • Global
From
Gout Disease Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Gout Disease Treatment Market - Global Strategic Business Report

  • Report
  • February 2026
  • 473 Pages
  • Global
From
Triamcinolone Market - Global Strategic Business Report - Product Thumbnail Image

Triamcinolone Market - Global Strategic Business Report

  • Report
  • February 2026
  • 378 Pages
  • Global
From
Ibuprofen API - Global Strategic Business Report - Product Thumbnail Image

Ibuprofen API - Global Strategic Business Report

  • Report
  • February 2026
  • 139 Pages
  • Global
From
Hydroxychloroquine - Global Strategic Business Report - Product Thumbnail Image

Hydroxychloroquine - Global Strategic Business Report

  • Report
  • February 2026
  • 293 Pages
  • Global
From
From
Uveitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Uveitis Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 413 Pages
  • Global
From
From
Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 182 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more